| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
9,960,000 |
| Market
Cap: |
6.18(M) |
| Last
Volume: |
424,352 |
Avg
Vol: |
423,184 |
| 52
Week Range: |
$0.62 - $0.62 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Wholesale |
| Level
III Sector: |
Medical Equipment Wholesale |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Nephros is a commercial-stage company that develops and sells water solutions. Co.'s medical water filters, are used by hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate. Co.'s subsidiary, Specialty Renal Products, Inc. (SRP), is a development-stage medical device company focused primarily on developing hemodiafiltration (HDF) technology. SRP is developing a second-generation of the OLpur H2H Hemodiafiltration System, a medical device that enables nephrologists to provide HDF treatment to patients with end stage renal disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
7,000 |
25,000 |
27,000 |
27,000 |
| Total Buy Value |
$17,130 |
$56,777 |
$60,133 |
$60,133 |
| Total People Bought |
1 |
2 |
2 |
2 |
| Total Buy Transactions |
1 |
2 |
4 |
4 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jacobs Joseph |
Director |
– • • |
2021-06-01 |
4 |
OE |
$2.70 |
$180,001 |
I/I |
66,667 |
3,544,492 |
|
- |
|
| Evans Daron |
CEO Specialty Renal Products |
• – – |
2021-05-27 |
4/A |
D |
$2.70 |
$1,885 |
I/I |
(698) |
8,669 |
|
- |
|
| Evans Daron |
CEO of Specialty Renal Product |
• – – |
2021-05-24 |
4 |
OE |
$2.70 |
$5,999 |
I/I |
2,222 |
9,018 |
|
- |
|
| Lobo Wesley S. |
Chief Marketing Officer |
• – – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
40,557 |
40,557 |
|
- |
|
| Jacobs Joseph |
|
• • • |
2021-01-27 |
4 |
OE |
$3.60 |
$62,260 |
D/D |
14,754 |
106,037 |
|
- |
|
| Amron Arthur H |
Director |
– • – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,666 |
3,666 |
|
- |
|
| Jacobs Joseph |
|
• • • |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,196 |
3,196 |
|
- |
|
| Gwydir Tom |
Director |
– • – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,666 |
6,031 |
|
- |
|
| Lask Alisa |
Director |
– • – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,666 |
7,143 |
|
- |
|
| Spandow Oliver J. |
Director |
– • – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,666 |
19,400 |
|
- |
|
| Persen Malcolm C |
Director |
– • – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,921 |
48,774 |
|
- |
|
| Astor Andrew |
President & CEO |
• • – |
2020-11-19 |
4 |
B |
$5.87 |
$5,867 |
D/D |
1,000 |
72,958 |
2.81 |
- |
|
| Spandow Oliver J. |
Director |
– • – |
2020-11-18 |
4 |
B |
$5.83 |
$8,749 |
D/D |
1,500 |
15,734 |
2.39 |
- |
|
| Jacobs Joseph |
|
• • • |
2020-10-15 |
4 |
A |
$6.00 |
$1,000,002 |
I/I |
166,667 |
3,605,471 |
|
- |
|
| Astor Andrew |
COO/CFO |
• • – |
2020-08-19 |
4 |
B |
$7.40 |
$7,030 |
D/D |
950 |
71,958 |
2.81 |
- |
|
| Astor Andrew |
CFO/COO |
• – – |
2020-05-28 |
4 |
B |
$6.96 |
$6,960 |
D/D |
1,000 |
71,008 |
2.74 |
- |
|
| Persen Malcolm C |
Director |
– • – |
2020-05-11 |
4 |
OE |
$7.65 |
$13,250 |
I/I |
1,732 |
5,194 |
|
- |
|
| Astor Andrew |
CFO/COO |
• – – |
2020-03-12 |
4 |
B |
$6.70 |
$6,700 |
D/D |
1,000 |
70,008 |
2.74 |
- |
|
| Evans Daron |
President and CEO |
• • – |
2020-03-12 |
4 |
B |
$6.65 |
$16,625 |
D/D |
2,500 |
134,215 |
2.81 |
- |
|
| Evans Daron |
President and CEO |
• • – |
2020-03-05 |
4 |
B |
$8.44 |
$21,109 |
D/D |
2,500 |
131,715 |
2.81 |
- |
|
| Astor Andrew |
CFO/COO |
• – – |
2020-03-05 |
4 |
B |
$8.46 |
$5,920 |
D/D |
700 |
69,008 |
2.74 |
- |
|
| Amron Arthur H |
Director |
– • – |
2019-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,448 |
3,448 |
|
- |
|
| Astor Andrew |
CFO/COO |
• – – |
2019-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,848 |
68,308 |
|
- |
|
| Spandow Oliver J. |
Director |
– • – |
2019-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,448 |
14,234 |
|
- |
|
| Gwydir Tom |
Director |
– • – |
2019-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,365 |
2,365 |
|
- |
|
136 Records found
|
|
Page 2 of 6 |
|
|
